Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hodgson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Physical Review Letters|March 17, 2011
c(2×2) water-hydroxyl layer on Cu(110): a wetting layer stabilized by Bjerrum defectsMatthew Forster, Rasmita Raval, Andrew Hodgson, et al.
Leukemia & Lymphoma|January 26, 2017
Chronic myeloid leukemia with a novel e8a1 BCR-ABL1 fusion: rapid molecular response with nilotinibMireille Crampe, Fatima Shakkak, Johanna Kelly, et al.
Nature Materials|March 10, 2009
A one-dimensional ice structure built from pentagonsJavier Carrasco, Angelos Michaelides, Matthew Forster, et al.
Journal of Medical Radiation Sciences|September 23, 2022
Clinical evaluation of deep learning and atlas-based auto-segmentation for critical organs at risk in radiation therapyEddie Gibbons, Matthew Hoffmann, Justin Westhuyzen, et al.
Journal of the American Chemical Society|July 22, 2020
Hydration of a 2D Supramolecular Assembly: Bitartrate on Cu(110)Chenfang Lin, George R Darling, Matthew Forster, et al.
Journal of the American Chemical Society|October 30, 2018
Ice Nucleation on a Corrugated SurfaceChenfang Lin, Gefen Corem, Oded Godsi, et al.
British Journal of Sports Medicine|August 16, 2022
Rise of intravenous nutrition products among professional team sport athletes: reasons to be concerned?Nathan Lewis, Andrew Hodgson, Tamim Khanbhai, et al.
European Journal of Haematology|August 21, 2024
Plasma monomeric ApoA1 and high-density lipoprotein bound ApoA1 are markedly decreased and associated with low levels of lipophilic antioxidants in sickle cell disease: A potential new pathway for therapyEric J Niesor, Anne Perez, Serge Rezzi, et al.
Chemical Reviews|May 28, 2016
Water at InterfacesOlle Björneholm, Martin H Hansen, Andrew Hodgson, et al.
Leukemia & Lymphoma|September 20, 2017
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLLNiamh Appleby, David O'Brien, Fiona M Quinn, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Physical Review Letters|March 17, 2011
c(2×2) water-hydroxyl layer on Cu(110): a wetting layer stabilized by Bjerrum defectsMatthew Forster, Rasmita Raval, Andrew Hodgson, et al.
Leukemia & Lymphoma|January 26, 2017
Chronic myeloid leukemia with a novel e8a1 BCR-ABL1 fusion: rapid molecular response with nilotinibMireille Crampe, Fatima Shakkak, Johanna Kelly, et al.
Nature Materials|March 10, 2009
A one-dimensional ice structure built from pentagonsJavier Carrasco, Angelos Michaelides, Matthew Forster, et al.
Journal of Medical Radiation Sciences|September 23, 2022
Clinical evaluation of deep learning and atlas-based auto-segmentation for critical organs at risk in radiation therapyEddie Gibbons, Matthew Hoffmann, Justin Westhuyzen, et al.
Journal of the American Chemical Society|July 22, 2020
Hydration of a 2D Supramolecular Assembly: Bitartrate on Cu(110)Chenfang Lin, George R Darling, Matthew Forster, et al.
Journal of the American Chemical Society|October 30, 2018
Ice Nucleation on a Corrugated SurfaceChenfang Lin, Gefen Corem, Oded Godsi, et al.
British Journal of Sports Medicine|August 16, 2022
Rise of intravenous nutrition products among professional team sport athletes: reasons to be concerned?Nathan Lewis, Andrew Hodgson, Tamim Khanbhai, et al.
European Journal of Haematology|August 21, 2024
Plasma monomeric ApoA1 and high-density lipoprotein bound ApoA1 are markedly decreased and associated with low levels of lipophilic antioxidants in sickle cell disease: A potential new pathway for therapyEric J Niesor, Anne Perez, Serge Rezzi, et al.
Chemical Reviews|May 28, 2016
Water at InterfacesOlle Björneholm, Martin H Hansen, Andrew Hodgson, et al.
Leukemia & Lymphoma|September 20, 2017
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLLNiamh Appleby, David O'Brien, Fiona M Quinn, et al.
Pageof 3